Metraipolis › archive › dc_a2ceb8cb5470

The silent signals: emerging safety concerns in bispecific antibody therapy for multiple myeloma — Europe PMC PMID:40880759

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40880759
DOI
10.3389/fmed.2025.1593405
License (as archived)
solo-consultazione
Archived
2026-11-10T16:37:28.636Z
SHA-256 of the archived text
c7bc5cf7e990a291d6750ecd5ae223e983c21daee0d09a820bbfaf6df5477857
Stable URL of this page
https://metraipolis.com/documento/dc_a2ceb8cb5470

How to cite

The silent signals: emerging safety concerns in bispecific antibody therapy for multiple myeloma — Europe PMC PMID:40880759 — Europe PMC (en), https://europepmc.org/article/MED/40880759 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a2ceb8cb5470 (Metraipolis archive dc_a2ceb8cb5470, sha256 c7bc5cf7e990a291d6750ecd5ae223e983c21daee0d09a820bbfaf6df5477857)
BibTeX
@misc{dca2ceb8cb5470,
  title = {The silent signals: emerging safety concerns in bispecific antibody therapy for multiple myeloma — Europe PMC PMID:40880759},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40880759},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a2ceb8cb5470; sha256 c7bc5cf7e990a291d6750ecd5ae223e983c21daee0d09a820bbfaf6df5477857},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40880759. Agents can read the archived copy with the MCP tool read_document.